The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy
Open accessAbstract
BackgroundFabry disease is an X-linked lysosomal deficiency of α-galactosidase A that results in cellular accumulation of galacto-conjugates such as globotriosylceramide, particularly in blood vessels. It is associated with early-onset stroke and kidney and heart failure. Methods and ResultsUsing [15 O] H 2 O and PET, we found increased resting regional cerebral blood flow in Fabry disease without evidence of occlusive vasculopathy or cerebral hypoperfusion. Because nitric oxide is known to play an important role in vascular tone and reactivity, we studied plasma nitrate, nitrite, and low-molecular-weight S-nitrosothiol levels by chemiluminescence. Skin biopsy specimens and archived brain tissue were also examined immunohistochemically for nitrotyrosine. Plasma nitrate, nitrite, and low-molecular-weight S-nitrosothiol were in the normal range; however, enhanced nitrotyrosine staining was observed in dermal and cerebral blood vessels. After a double-blind, placebo-controlled trial of α-galactosidase A therapy, the resting regional cerebral blood flow in the treated group was significantly reduced, with a notable decrease of nitrotyrosine staining in dermal blood vessels. ConclusionsThese findings suggest a chronic alteration of the nitric oxide pathway in Fabry disease, with critical protein nitration that is reversible with enzyme replacement therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Spatial registration and normalization of images
Friston, K. J., Ashburner, J., Frith, C. D., Poline, J. ‐., Heather, J. D., & Frackowiak, R. S. J. (1995) · Human Brain Mapping · doi:10.1002/hbm.460030303 · Cited by 3,744
Design and construction of a realistic digital brain phantom
Collins, D. L., Zijdenbos, A. P., Kollokian, V., Sled, J. G., Kabani, N. J., Holmes, C. J., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.712135 · Cited by 1,822
Wink, D. A., & Mitchell, J. B. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00092-6 · Cited by 1,606
Nitric oxide : biology and pathobiology
Ignarro, L. J. (2000) · Cited by 1,306
Enzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Schiffmann, R., Kopp, J. B., Austin III, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001) · JAMA · doi:10.1001/jama.285.21.2743 · Cited by 1,302
Self-citationCuzzocrea, S., Riley, D. P., Caputi, A. P., & Salvemini, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01484-4 · Cited by 1,087
Enzymatic Defect in Fabry's Disease: Ceramidetrihexosidase Deficiency
Brady, R. O., Gal, A. E., Bradley, R. M., Martensson, E., Warshaw, A. L., & Laster, L. (1967) · New England Journal of Medicine · doi:10.1056/nejm196705252762101 · Cited by 1,053
Self-citationBrain blood flow measured with intravenous H2(15)O. I. Theory and error analysis.
Herscovitch, P., Markham, J., & Raichle, M. E. (1983) · PubMed · Cited by 835
Self-citationRegulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
FARACI, F. M., & HEISTAD, D. D. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.53 · Cited by 780
Neurology in Clinical Practice
Bradley, G. W. (2004) · Medical Entomology and Zoology · Cited by 746
Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice
Matoba, T., Shimokawa, H., Nakashima, M., Hirakawa, Y., Mukai, Y., Hirano, K., Kanaide, H., & Takeshita, A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10506 · Cited by 722
(2001) · Molecular Therapy · doi:10.1006/mthe.2001.0396 · Cited by 680
α-Galactosidase A deficiency. Fabry disease
Desnick, R. J. (2001) · Cited by 605
Estévez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., Tarpey, M. M., Barbeito, L., & Beckman, J. S. (1999) · Science · doi:10.1126/science.286.5449.2498 · Cited by 596
Numerical Recipes in FORTRAN 90: The Art of Parallel Scientific Computing
Press, W. H., Teukolsky, S. A., Vetterling, W. T., et al. (1996) · Cited by 469
Physiological and pathophysiological roles of nitric oxide in the central nervous system
Szabó, C. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00159-1 · Cited by 297
Cerebrovascular complications of Fabry's disease
Mitsias, P., & Levine, S. R. (1996) · Annals of Neurology · doi:10.1002/ana.410400105 · Cited by 295
Quantitative analysis of epidermal innervation in Fabry disease
Scott, L. J. C., Griffin, J. W., Luciano, C. A., Barton, N. W., Banerjee, T. K., Crawford, T. O., McArthur, J. C., Tournay, A. E., & Schiffmann, R. (1999) · Neurology · doi:10.1212/wnl.52.6.1249 · Cited by 155
Self-citationEndothelium-derived free radicals: for worse and for better
Vanhoutte, P. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11832 · Cited by 150
Gladwin, M. T., Schechter, A. N., Shelhamer, J. H., Pannell, L. K., Conway, D. A., Hrinczenko, B. W., Nichols, J. S., Pease‐Fye, M. E., Noguchi, C. T., Rodgers, G. P., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7637 · Cited by 133
Self-citationEnhanced Endothelium-Dependent Vasodilation in Fabry Disease
Altarescu, G., Moore, D. F., Pursley, R. H., Campia, U., Goldstein, S. R., Bryant, M. B., Panza, J. A., & Schiffmann, R. (2001) · Stroke · doi:10.1161/01.str.32.7.1559 · Cited by 131
Self-citationEffects of oxygen radicals on cerebral arterioles
Wei, E. P., Christman, C. W., Kontos, H. A., & Povlishock, J. T. (1985) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1985.248.2.h157 · Cited by 127
The Chemical Properties of Nitric Oxide and Related Nitrogen Oxides
Fukuto, J. M., Cho, J. Y., & Switzer, C. H. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50003-4 · Cited by 95
Antioxidants Inhibit ATP-Sensitive Potassium Channels in Cerebral Arterioles
Wei, E. P., Kontos, H. A., & Beckman, J. S. (1998) · Stroke · doi:10.1161/01.str.29.4.817 · Cited by 39
Activation of NOS by Ca2+-Dependent and Ca2+-Independent Mechanisms
Fleming, I., & Busse, R. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50039-3 · Cited by 7
Moore, D. F., Pursley, R. H., Altarescu, G., Schiffmann, R., & Dimitriadis, E. K. (2002) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2001.941723 · Cited by 3
Self-citation
Cited by
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I., Kernan, W. N., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492
Germain, D. P. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-30 · Cited by 1,198
Desnick, R. J., Brady, R., Barranger, J., Collins, A. J., Germain, D. P., Goldman, M., Grabowski, G., Packman, S., & Wilcox, W. R. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-4-200302180-00014 · Cited by 766
Self-citationPrevalence of Fabry disease in patients with cryptogenic stroke: a prospective study
Rolfs, A., Böttcher, T., Zschiesche, M., Morris, P., Winchester, B., Bauer, P., Walter, U., Mix, E., Löhr, M., Harzer, K., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67635-0 · Cited by 464
Metadata
- Authors
- Moore, D. F., Scott, L. T. C., Gladwin, M. T., Altarescu, G., Kaneski, C., Suzuki, K., Pease-Fye, M., Ferri, R., Brady, R. O., Herscovitch, P., & Schiffmann, R.
- Venue
- Circulation
- Published
- 2001-09-25
- Volume
- 104
- Issue
- 13
- Pages
- 1506-1512
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2058657632
- Cited by
- 252
- References
- 27
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.